Former Chief Executive Officer · NEUROCRINE BIOSCIENCES INC (NBIX)

Kevin C. Gorman

A named executive officer of NEUROCRINE BIOSCIENCES in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$16,018,637

Salary $779,357Stock awards $7,000,139Bonus $1,141,950

FY2023: $15,750,812

1st of 7 named executive officers at Neurocrine Biosciences by FY2024 total.

7 named officers on file for NEUROCRINE BIOSCIENCES, FY2024

Kevin C. Gorman’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 14 equity grants, each cited to its filing
  • NBIX’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NEUROCRINE BIOSCIENCES’s whole pay program stands against its peers

  • NEUROCRINE BIOSCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NBIX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2025 (DEF 14A).

Free

Get Kevin C. Gorman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Kevin C. Gorman compensation by year

NEUROCRINE BIOSCIENCES Summary Compensation Table · all 3 fiscal years held
In US dollars, as NEUROCRINE BIOSCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$860,000$946,000$779,357
Bonus$989,000$1,040,600$1,141,950
Stock awards$5,125,079$7,021,386$7,000,139
Option awards$4,875,106$6,678,790$6,999,698
Non-equity incentive$0$0$0
Pension and deferred compensation$0——
All other$53,342$64,036$97,493
Total$11,902,527$15,750,812$16,018,637

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEUROCRINE BIOSCIENCES INC DEF 14A filed April 9, 2025, accession 0000914475-25-000091, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEUROCRINE BIOSCIENCES INC filed document, accession 0000914475-25-000091. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2025.

$11.9M
$15.8M
$16.0M
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU50,979$6,958,634—
RSU28,686$3,915,639—
PSU26,576$3,627,624—
RSU22,415$3,059,648—
RSU16,130$2,201,745—
RSU10,283$1,403,630—
RSU4,318$589,407—
Option4,744—$117.63
Option37,930—$79.02
Option72,397—$103.52
Option89,176—$133.84

Per the Outstanding Equity Awards at Fiscal Year-End table in NEUROCRINE BIOSCIENCES INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

NEUROCRINE BIOSCIENCES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Kevin C. Gorman · this pageFormer Chief Executive Officer$16,018,637
Kyle W. GanoChief Executive Officer$8,535,422
Sanjay KeswaniChief Medical Officer Jude Onyia, Ph.D. (8) Chief Scientific Officer$7,035,851
Jude OnyiaChief Scientific Officer$7,035,851
Eiry W. RobertsChief Medical Officer$6,764,318
Matthew C. AbernethyChief Financial Officer$6,595,201
Eric BenevichChief Commercial Officer$6,306,164

Board service

NEUROCRINE BIOSCIENCES board · FY2021–FY2025
Director compensation in US dollars, as NEUROCRINE BIOSCIENCES reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$0$400,037$0$470,037
FY2024—————
FY2023$0$0$0——
FY2022$0—$0——
FY2021$0—$0——

Each year as the company reported it in NEUROCRINE BIOSCIENCES's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: NEUROCRINE BIOSCIENCES pays directors a $60,000 cash retainer and $400,000 in RSUs/Options. As stated in NEUROCRINE BIOSCIENCES's FY2025 proxy.

Committees

Science and Medical Technology

The full NEUROCRINE BIOSCIENCES compensation record

free company brief

This page is one person within NEUROCRINE BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEUROCRINE BIOSCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEUROCRINE BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kevin C. Gorman's compensation dossier · One-time report. No refunds.